| You
are here: Home: BCU 6|2003: Kathy
S Albain, MD: Select publications
Select publications
Publications discussed by Dr Albain
Albain KS et al. Adjuvant chemohormonal therapy for primary
breast cancer should be sequential instead of concurrent: Initial
results
from intergroup trial 0100 (SWOG-8814). Proc ASCO 2002;
Abstract
143.
Albain K et al. Open-label, phase II, multicenter trial
of ZD1839 (‘Iressa’) in patients with advanced breast
cancer.
Breast Cancer Res Treat 2002; Abstract
20.
Albain KS et al. Overall survival after cyclophosphamide,
Adriamycin, 5-FU, and tamoxifen (CAFT) is superior to T alone
in postmenopausal,
receptor(+), node(+) breast cancer: New findings from Phase III
Southwest Oncology Group Intergroup Trial S8814 (INT-0100). Proc
ASCO 2001; Abstract
94.
Ganz PA et al. Late cardiac effects of adjuvant CMF vs
CAF in women with node negative breast cancer treated on SWOG
8897: Initial
results from SWOG 9342. Breast Cancer Res Treat 2002;Abstract
10.
Robert N et al. Phase III comparative study of trastuzumab
and paclitaxel with and without carboplatin in patients with
HER-2/neu
positive advanced breast cancer. Breast Cancer Res Treat 2002;Abstract
35.
Robertson JFR et al. A phase II study of ZD1839 (‘Iressa’)
in tamoxifen-resistant ER-positive and endocrine-insensitive (ER-negative)
breast cancer. Breast Cancer Res Treat 2002; Abstract
357.
Slamon DJ et al. Use of chemotherapy plus a monoclonal
antibody against HER2 for metastatic breast cancer that overexpresses
HER2. N Engl J Med 2001;344(11):783-92. Abstract
|
